Manchanda, Ranjit http://orcid.org/0000-0003-3381-5057
Evans, D. Gareth
Antoniou, Antonis C.
Brentnall, Adam
Funding for this research was provided by:
Yorkshire Cancer Research (RA/2021/R2/110)
Article History
Received: 16 October 2023
Revised: 16 October 2023
Accepted: 24 October 2023
First Online: 15 March 2024
Competing interests
: RM reports receiving grants from Yorkshire Cancer Research, GSK, NHS Innovation Accelerator (NIA), and Barts Charity into genetic testing, screening and prevention research; and honoraria for advisory board membership from Astrazeneca/MSD/GSK/EGL. RM is Topic Advisor for the NICE GuidelineāOvarian cancer: identifying and managing familial and genetic risk. ACA is listed as a creator of the BOADICEA model which has been licensed by Cambridge Enterprise. DGE received consulting fees from Astrazeneca and Everything Genetics Ltd. AB declares grants from Cancer Research UK, Breast Cancer Now and royalties arising from use of the Tyrer-Cuzick (IBIS) breast cancer risk evaluation tool.